http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6455553-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef416fe4f66ebb1021cecfb0ba5ae45d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2000-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e464e7e4e24ee805ba4e75adcc210483 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b36b2fc6173d0c3a5bd26815f9ea9250 |
| publicationDate | 2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6455553-B1 |
| titleOfInvention | Method for treating a demyelinating condition |
| abstract | The present invention provides a method for treating a demyelinating condition in a subject in need of treatment, by administering to the subject an amount of a Ca 2+ -channel blocker effective to treat the demyelinating condition. The present invention is also directed to a method for treating a demyelinating condition in a subject in need of treatment, by administering to the subject a Ca 2+ -channel blocker in combination with a glutamate inhibitor, in amounts effective to treat the demyelinating condition. Also disclosed is a pharmaceutical composition comprising a Ca 2+ -channel blocker, a glutamate inhibitor, and a pharmaceutically-acceptable carrier. Additionally, the present invention provides a method for treating a demyelinating condition in a subject in need of treatment, by administering to the subject a Ca 2+ -channel blocker in combination with a hypertensive agent, in amounts effective to treat the demyelinating condition. Finally, the present invention discloses a pharmaceutical composition comprising a Ca 2+ -channel blocker, a hypertensive agent, and a pharmaceutically-acceptable carrier. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003055036-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012129940-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004096217-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9044443-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7816384-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8278276-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7915226-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009169614-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008146506-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009069290-A1 |
| priorityDate | 2000-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 402.